PICTET ASSET MANAGEMENT LTD - ULTRAGENYX PHARMACEUTICAL IN ownership

ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 176 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q3 2016. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
PICTET ASSET MANAGEMENT LTD ownership history of ULTRAGENYX PHARMACEUTICAL IN
ValueSharesWeighting
Q2 2021$420,000
-26.2%
4,400
-12.0%
0.00%
-100.0%
Q1 2021$569,000
-12.6%
5,000
+6.4%
0.00%0.0%
Q4 2020$651,000
+68.7%
4,7000.0%0.00%0.0%
Q3 2020$386,000
-98.0%
4,700
-98.5%
0.00%
-97.6%
Q2 2019$19,452,000
-51.4%
306,325
-46.9%
0.04%
-52.3%
Q1 2019$40,018,000
+2.0%
576,961
-36.0%
0.09%
-10.2%
Q4 2018$39,223,000
-13.0%
902,103
+52.8%
0.10%
+3.2%
Q3 2018$45,066,000
-8.5%
590,339
-7.9%
0.10%
-19.5%
Q2 2018$49,272,000
-10.5%
640,973
-40.6%
0.12%
-13.2%
Q1 2018$55,037,000
+17.0%
1,079,369
+6.4%
0.14%
+12.4%
Q4 2017$47,051,000
+17.7%
1,014,469
+35.2%
0.12%
+7.1%
Q3 2017$39,967,000
+26.0%
750,407
+27.4%
0.11%
+15.3%
Q2 2017$31,729,000
+12.6%
589,211
+41.7%
0.10%
+6.5%
Q1 2017$28,181,000
+3.4%
415,778
+7.3%
0.09%
-8.9%
Q4 2016$27,249,000
+13.6%
387,550
+14.6%
0.10%
+12.2%
Q3 2016$23,986,000
+68.7%
338,119
+73.8%
0.09%
+60.7%
Q2 2016$14,220,000
+2964.7%
194,527
+2459.6%
0.06%
+2700.0%
Q1 2016$464,000
-45.6%
7,6000.0%0.00%
-50.0%
Q4 2015$853,000
+205.7%
7,600
+162.1%
0.00%
+300.0%
Q3 2015$279,000
-92.7%
2,900
-90.8%
0.00%
-93.8%
Q2 2015$3,821,000
+60.1%
31,600
-25.3%
0.02%
+60.0%
Q1 2015$2,387,00042,3000.01%
Other shareholders
ULTRAGENYX PHARMACEUTICAL IN shareholders Q3 2016
NameSharesValueWeighting ↓
Abingworth LLP 38,100$2,928,0001.67%
Opaleye Management Inc. 80,000$6,149,0001.59%
HIGHLINE CAPITAL MANAGEMENT, L.P. 410,000$31,517,0001.06%
Opus Point Partners Management, LLC 6,311$485,0001.05%
SECTOR GAMMA AS 68,015$5,228,0000.87%
Capital Impact Advisors, LLC 27,074$2,061,0000.76%
FORTALEZA ASSET MANAGEMENT INC/ 1,130$87,0000.71%
CAPITAL INTERNATIONAL LTD /CA/ 46,957$3,610,0000.63%
Virtus ETF Advisers LLC 8,794$676,0000.60%
Rock Springs Capital Management LP 200,000$15,374,0000.59%
View complete list of ULTRAGENYX PHARMACEUTICAL IN shareholders